Related Experiment Video
Updated: Aug 3, 2026
10:42
Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
Published on: April 11, 2019
Ex vivo hematopoietic cell expansion: a theoretical and technological challenge
1Formation Associee Claude Bernard, Unite de Recherche sur les Greffes de Cellules Souches Hematopoietiques, Paris, France.
Nouvelle Revue Francaise D'Hematologie
|January 1, 1995
Summary
Ex vivo hematopoietic cell expansion (HCE) using colony-stimulating factors (CSF) can amplify progenitor cells. Critical factors include CSF choice and culture parameters to ensure stem cell maintenance for long-term engraftment.
Area of Science:
- Hematology
- Cell Biology
- Biotechnology
Background:
- Hematopoietic cell expansion (HCE) in vitro is crucial for bone marrow transplantation and gene therapy.
- Current methods focus on optimizing colony-stimulating factor (CSF) combinations for cell amplification.
Purpose of the Study:
- To investigate the efficacy of ex vivo HCE using CSF combinations.
- To determine if CSF combinations maintain or expand the stem cell compartment for long-term engraftment.
Main Methods:
- Utilizing liquid culture systems with optimal CSF combinations.
- Analyzing the amplification of late progenitor pools and stem cell maintenance.
Main Results:
- Preclinical studies demonstrate successful maintenance and expansion of hematopoietic cells.
- CSF combinations and culture parameters critically influence HCE outcomes.
Conclusions:
- Ex vivo HCE holds promise for reducing transplantation effort and enabling therapeutic gene transfer.
- Future research must validate ex vivo expanded cell applicability and monitor for tumoral cell expansion.
